Valerio Therapeutics: Pioneering the Future of Cancer Therapy through Molecular Precision and Global Collaboration
In the realm of cutting-edge biotechnology, Valerio Therapeutics stands tall as a clinical-stage entity committed to revolutionizing cancer treatment. Formerly known as Onxeo, this avant-garde company specializes in the development of novel cancer drugs, employing a groundbreaking approach that targets tumor DNA functions through unprecedented mechanisms of action. At the heart of Valerio Therapeutics’ innovation…